The measurement of the level of prostate-specific antigen (PSA) in serum was included in the screening of PCa in the early 1990s all over the world, which led to an increase in incidence [3], but it simultaneously shifted this type of cancer to a predominantly localized form. This evidence concerns the gene KLK3 and cancer.